SHP Wealth Management’s Intelligent Bio Solutions INBS Stock Holding History

SHP Wealth Management’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$238	–	1869
2025 Q4	$238	Buy	+25	New	+$204	﹤0.01%	1454

Other funds holding INBS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Curio Wealth Annapolis, Maryland $322M AUM 16.26% 1-Year Est. Return

SHP Wealth Management's INBS Position: Q1 2026 in Review

SHP Wealth Management sold out of Intelligent Bio Solutions (INBS) in Q1 2026, closing a stake of 25 shares — an estimated $238 sold.

SHP Wealth Management first reported a position in INBS in Q4 2025 and held it in 1 quarter. The position peaked at $238 in Q4 2025. 9 funds tracked by Wall St. Rank hold INBS as of Q1 2026.

SHP Wealth Management reported no remaining Intelligent Bio Solutions position as of Q1 2026 after selling out during the quarter.
SHP Wealth Management sold 25 Intelligent Bio Solutions shares in Q1 2026, an estimated $238.
SHP Wealth Management first reported a position in Intelligent Bio Solutions in Q4 2025 and held it in 1 quarter.
SHP Wealth Management's Intelligent Bio Solutions position peaked at $238 in Q4 2025.
9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.